It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

medicine

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Japan to donate 30 million additional COVID-19 vaccine doses

National Sep 23, 2021

Japan to donate 30 million additional COVID-19 vaccine doses

The pledge, made at a virtual summit on the pandemic hosted by U.S. President Joe Biden, brings Japan's total commitments to 60 million doses.

Pfizer COVID-19 shot safely bolsters antibodies in younger kids

World Sep 20, 2021

Pfizer COVID-19 shot safely bolsters antibodies in younger kids

In a trial, two shots of a 10 microgram dose — one-third of the adult shot — produced antibody levels comparable to those seen in a trial of 16- to 25-year-olds who got the adult dose.

Home COVID-19 care surged as Japan's hospitals filled up, but treatment options were limited

National | FOCUS Sep 19, 2021

Home COVID-19 care surged as Japan's hospitals filled up, but treatment options were limited

by Ryusei Takahashi

Providing at-home treatment for coronavirus patients presents an entirely different dilemma for the nation's already exhausted medical personnel.

The explanation for seemingly irrational COVID-19 behavior

Commentary / World Sep 15, 2021

The explanation for seemingly irrational COVID-19 behavior

by Tyler Cowen

Before the vaccines came along, it made great sense to enforce masking norms. If infections could be shifted into the future, a vaccinated citizenry would be much better protected.

The hospital conundrum: Why Tokyo’s health system is overflowing with COVID-19 patients

National | FOCUS Sep 14, 2021

The hospital conundrum: Why Tokyo’s health system is overflowing with COVID-19 patients

by Osamu Tsukimori

Many hospitals — both those that are private as well as some nationally managed institutions — have been slow to set aside beds for infected patients.

The U.K.’s bizarre $1.7 billion vaccine rug-pull

Commentary / World Sep 14, 2021

The U.K.’s bizarre $1.7 billion vaccine rug-pull

by Lionel Laurent

The British government abruptly canceled its supply contract, having found Valneva in breach of its obligations without specifying how — something Valneva contests.

Vaccines versus COVID-19: The great immunity debate

Commentary / World Sep 8, 2021

Vaccines versus COVID-19: The great immunity debate

by Faye Flam

There’s emerging evidence that getting sick provides better protection than at least one brand of shot. But people still need to get the jab.

Lawmakers probe ‘anomalies’ in approval of Biogen Alzheimer’s drug

World Sep 3, 2021

Lawmakers probe ‘anomalies’ in approval of Biogen Alzheimer’s drug

by John Tozzi and Robert Langreth

The congressional inquiry adds to pressure on the U.S. agency charged with regulating products that account for one-fifth of consumer spending.

COVID-19 vaccines may become a viable business. That’s a problem.

Commentary / World Sep 2, 2021

COVID-19 vaccines may become a viable business. That’s a problem.

by David Fickling

Inoculations have been distributed to almost every person on the planet. But, traditionally, they been unprofitable for the pharmaceutical industry.

Japan finds another Moderna vial suspected to contain foreign substance

National Sep 1, 2021

Japan finds another Moderna vial suspected to contain foreign substance

Kanagawa Prefecture said it had put the suspected lot of the firm's COVID-19 vaccine on hold after about 3,790 people had already received shots from the same lot.

Foreign substances in Japan's Moderna shots: Here's what you need to know

National | EXPLAINER Aug 30, 2021

Foreign substances in Japan's Moderna shots: Here's what you need to know

by Osamu Tsukimori

Other possibly contaminated batches have been reported in recent days, but experts say health risks are low.

New treatment emerges amid COVID-19 vaccine efficacy concerns

Commentary / World Aug 29, 2021

New treatment emerges amid COVID-19 vaccine efficacy concerns

by Therese Raphael

With studies showing COVID-19 vaccine efficacy declining faster than expected, boosters aren’t the only option, and in some cases they may not even be the best.

« 1 … 25 26 27 … 46 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times